174 results on '"Ajani, Andrew"'
Search Results
2. Associations Between Metabolic Syndrome and Long-Term Mortality in Patients who underwent Percutaneous Coronary Intervention: An Australian Cohort Analysis
3. Sex Differences in Pharmacotherapy and Long-Term Outcomes in Patients With Ischaemic Heart Disease and Comorbid Left Ventricular Dysfunction
4. Cell-free DNA as a potential biomarker for acute myocardial infarction: A systematic review and meta-analysis
5. Real-world long-term survival after non-emergent percutaneous coronary intervention to unprotected left main coronary artery — From the Melbourne Interventional Group (MIG) registry
6. Corrigendum to ‘Temporal Change in the Remaining Life Expectancy in People Who Underwent Percutaneous Coronary Intervention’ The American Journal of Cardiology Volume 187, 15 January 2023, Pages 154-161
7. Trends in Intra-Aortic Balloon Pump Use in Cardiogenic Shock After the SHOCK-II Trial
8. Characteristics of Radial Artery Coronary Bypass Graft Failure and Outcomes Following Subsequent Percutaneous Coronary Intervention
9. Harmonising Individual Patient Level Cardiac Registry Data Across the Asia Pacific Region—A Feasibility Study of In-Hospital Outcomes of STEMI Patients From the Asia Pacific Evaluation of Cardiovascular Therapies (ASPECT) Network
10. Temporal Change in the Remaining Life Expectancy in People Who Underwent Percutaneous Coronary Intervention
11. Trends and Real-World Safety of Patients Undergoing Percutaneous Coronary Intervention for Symptomatic Stable Ischaemic Heart Disease in Australia
12. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
13. Reperfusion Times and Outcomes in Patients With ST-Elevation Myocardial Infarction Presenting Without Pre-Hospital Notification
14. Adverse 30-Day Clinical Outcomes and Long-Term Mortality Among Patients With Preprocedural Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
15. ORSIRO (ULTRATHIN-STRUT, BIODEGRADABLE-POLYMER, SIROLIMUS-ELUTING STENTS) VERSUS THIN-STRUT, DURABLE-POLYMER,EVEROLIMUS-ELUTING STENTS FOR PERCUTANEOUS CORONARY REVASCULARISATION IN THE STEMI POPULATION
16. Long-term mortality in asymptomatic patients with stable ischemic heart disease undergoing percutaneous coronary intervention
17. Sex Differences in Pharmacotherapy and Long-Term Outcomes in Patients with Ischaemic Heart Disease and Comorbid Left Ventricular Dysfunction
18. Totally Occluded Culprit Coronary Artery in Patients with Non-ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
19. Temporal Trends in Patient Risk Profile and Clinical Outcomes Following Percutaneous Coronary Intervention
20. Differences in outcome of percutaneous coronary intervention between Indigenous and non-Indigenous people in Victoria, Australia: a multicentre, prospective, observational, cohort study
21. Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial
22. Comparison of Outcomes of Coronary Artery Disease Treated by Percutaneous Coronary Intervention in 3 Different Age Groups (<45, 46-65, and >65 Years)
23. Effect of Age on Clinical Outcomes in Elderly Patients (>80 Years) Undergoing Percutaneous Coronary Intervention: Insights From a Multi-Centre Australian PCI Registry
24. Takotsubo Cardiomyopathy Complicated by Cardiogenic Shock Secondary to Left Ventricular Outflow Tract Obstruction and Severe Mitral Regurgitation
25. Comparison of Long-Term Outcomes After Percutaneous Coronary Intervention in Patients With Insulin-Treated Versus Non-Insulin Treated Diabetes Mellitus
26. Rescue PCI in the management of STEMI: Contemporary results from the Melbourne Interventional Group registry
27. Comparison of Long-Term Mortality in Patients With Single Coronary Narrowing and Diabetes Mellitus to That of Patients With Multivessel Coronary Narrowing Without Diabetes Mellitus
28. Outcomes of Percutaneous Coronary Intervention in Patients With Rheumatoid Arthritis
29. Cost-Effectiveness of Transcatheter Aortic Valve Intervention (TAVI) Compared to Surgical Aortic Valve Replacement (SAVR) in Low- to Intermediate-Surgical-Risk Patients
30. The Impact of Out-of-Hours Presentation on Clinical Outcomes in ST-Elevation Myocardial Infarction
31. Long-term outcomes following percutaneous coronary intervention to an unprotected left main coronary artery in cardiogenic shock
32. Short- and long-term outcomes of out-of-hospital cardiac arrest following ST-elevation myocardial infarction managed with percutaneous coronary intervention
33. Late Post- Infarction Left Ventricular Pseudoaneurysm: A Case Report
34. Impact of Pre-Procedural Blood Pressure on Long-Term Outcomes Following Percutaneous Coronary Intervention
35. TCT-505 Impact of Sex and Door-to-Balloon Times on Long-Term Mortality in Patients Presenting With ST-Segment Elevation Myocardial Infarction (STEMI)
36. Impact of Gender and Door-to-Balloon Times on Long-Term Mortality in Patients Presenting With ST-Elevation Myocardial Infarction
37. Temporal Changes in Characteristics, Treatment and Outcomes of Heart Failure Patients Undergoing Percutaneous Coronary Intervention Findings From Melbourne Interventional Group Registry
38. Trends and predictors of recurrent acute coronary syndrome hospitalizations and unplanned revascularization after index acute myocardial infarction treated with percutaneous coronary intervention
39. One-Year Outcomes of Patients With Established Coronary Artery Disease Presenting With Acute Coronary Syndromes
40. Heart Rate as a Predictor of Outcome Following Percutaneous Coronary Intervention
41. Australian Trends in Procedural Characteristics and Outcomes in Patients Undergoing Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction
42. Trends and Impact of Door-to-Balloon Time on Clinical Outcomes in Patients Aged <75, 75 to 84, and ≥85 Years With ST-Elevation Myocardial Infarction
43. Evolution of Australian Percutaneous Coronary Intervention (from the Melbourne Interventional Group [MIG] Registry)
44. OUTCOMES OF PRE-LOADING VS IN-LAB LOADING WITH PRASUGREL AND TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROMES (ACS) UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI)
45. ASSOCIATION BETWEEN USE OF STATINS AND OUTCOMES IN HEART FAILURE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
46. Long-Term Survival Is Adversely Affected by Any Use of Saphenous Vein Graft in Coronary Bypass Surgery
47. The Change of Coronary Grafting Strategy in a Single Institution Almost 20 Years Prior
48. Impact of door-to-balloon time on long-term mortality in high- and low-risk patients with ST-elevation myocardial infarction
49. TCT-195 Predictors of Recurrent Acute Coronary Syndrome Hospitalisations Following Acute Myocardial Infarction
50. TCT-187 Safety of Early Discharge Following Percutaneous Coronary Intervention (PCI) for STEMI
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.